Lexston Life Sciences Corp
Lexston Mining Corporation engages in the acquisition and exploration of mineral properties in Canada. It holds a 100% interest in the Dory property consisting of four non-surveyed contiguous mineral claims totaling 1,348 hectares located within the Alberni Mining Division of British Columbia. The company is based in Vancouver, Canada.
Lexston Life Sciences Corp (LEXTF) - Net Assets
Latest net assets as of November 2025: $786.85K USD
Based on the latest financial reports, Lexston Life Sciences Corp (LEXTF) has net assets worth $786.85K USD as of November 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($925.87K) and total liabilities ($139.01K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $786.85K |
| % of Total Assets | 84.99% |
| Annual Growth Rate | -12.57% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 4.07 |
Lexston Life Sciences Corp - Net Assets Trend (2021–2024)
This chart illustrates how Lexston Life Sciences Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Lexston Life Sciences Corp (2021–2024)
The table below shows the annual net assets of Lexston Life Sciences Corp from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-05-31 | $711.08K | -11.46% |
| 2023-05-31 | $803.10K | -8.08% |
| 2022-05-31 | $873.71K | -17.89% |
| 2021-05-31 | $1.06 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lexston Life Sciences Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 350361200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (May 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $5.09 Million | 715.93% |
| Total Equity | $711.08K | 100.00% |
Lexston Life Sciences Corp Competitors by Market Cap
The table below lists competitors of Lexston Life Sciences Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Strategic Partners A/S
F:1TB0
|
$1.31 Million |
|
SPEQTA AB
F:23WA
|
$1.31 Million |
|
Dogwood Therapeutics, Inc.
NASDAQ:DWTX
|
$1.31 Million |
|
GLACIER LAKE RES
F:KDM
|
$1.31 Million |
|
RIGHTBRIDGE VENTURES GRP
F:K0B0
|
$1.31 Million |
|
Source Physical Palladium P
XETRA:8PSC
|
$1.31 Million |
|
AS Ekspress Grupp
F:DYC
|
$1.31 Million |
|
TRAKM8 HLDGS PLC LS -01
F:T8H
|
$1.31 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lexston Life Sciences Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 803,095 to 711,080, a change of -92,015 (-11.5%).
- Net loss of 867,713 reduced equity.
- New share issuances of 402,323 increased equity.
- Other factors increased equity by 373,375.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-867.71K | -122.03% |
| Share Issuances | $402.32K | +56.58% |
| Other Changes | $373.38K | +52.51% |
| Total Change | $- | -11.46% |
Book Value vs Market Value Analysis
This analysis compares Lexston Life Sciences Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 18.87x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.30x to 18.87x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-05-31 | $1.06 | $0.32 | x |
| 2022-05-31 | $0.74 | $0.32 | x |
| 2023-05-31 | $0.03 | $0.32 | x |
| 2024-05-31 | $0.02 | $0.32 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lexston Life Sciences Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -122.03%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.06x
- Recent ROE (-122.03%) is above the historical average (-152.00%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -82.34% | -587.57% | 0.14x | 1.04x | $-982.53K |
| 2022 | -265.56% | -642.70% | 0.38x | 1.09x | $-2.41 Million |
| 2023 | -138.06% | 0.00% | 0.00x | 1.01x | $-1.19 Million |
| 2024 | -122.03% | 0.00% | 0.00x | 1.06x | $-938.82K |
Industry Comparison
This section compares Lexston Life Sciences Corp's net assets metrics with peer companies in the Other Industrial Metals & Mining industry.
Industry Context
- Industry: Other Industrial Metals & Mining
- Average net assets among peers: $2,436,539,064
- Average return on equity (ROE) among peers: -72.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lexston Life Sciences Corp (LEXTF) | $786.85K | -82.34% | 0.18x | $1.31 Million |
| Asia Broadband Inc (AABB) | $-384.18K | 0.00% | 0.00x | $228.54 |
| Altair Resources Inc (AAEEF) | $519.85K | -583.77% | 3.27x | $165.38K |
| Aftermath Silver Ltd (AAGFF) | $26.16 Million | -26.37% | 0.41x | $99.81 Million |
| Anglo American plc (AAUKF) | $24.32 Billion | 6.55% | 1.06x | $26.36 Billion |
| Abacus Mining & Exploration Corporation (ABCFF) | $-123.88K | 0.00% | 0.00x | $1.95 Million |
| Vision Lithium Inc (ABEPF) | $-384.45K | 0.00% | 0.00x | $3.75 Million |
| Arbor Metals Corp (ABRMF) | $700.32K | -22.12% | 0.03x | $3.05 Million |
| ACG Metals Limited (ACGAF) | $3.51 Million | -77.72% | 0.31x | $121.32 Million |
| ACME Lithium Inc (ACLHF) | $-1.00 Million | 0.00% | 0.00x | $561.74K |
| ACMNF (ACMNF) | $11.40 Million | -19.68% | 0.16x | $14.34 Million |